C7A.012 Malignant carcinoid tumor of the ileum

Name of the Condition

• Malignant Carcinoid Tumor of the Ileum (ICD code C7A.012)
• Also known as ileal carcinoid or small intestine neuroendocrine tumor.

Summary

• Malignant carcinoid tumor of the ileum is a rare cancer originating from neuroendocrine cells in the ileum, part of the small intestine. These tumors may secrete hormones leading to symptoms related to hormone imbalance.

Causes

• The exact cause is often unknown, but it may involve genetic mutations. Certain genetic syndromes, such as multiple endocrine neoplasia type 1 (MEN1), can also contribute to the development.

Risk Factors

• Age: More common in people over 50.
• Genetic Predisposition: Family history of neuroendocrine tumors or genetic conditions like MEN1.
• Gender: Slightly more common in women.

Symptoms

• Abdominal pain, cramping, or discomfort.
• Diarrhea or changes in bowel habits.
• Flushing or redness of the face and neck.
• Heart palpitations or rapid heartbeat due to hormone release.
• Weight loss and fatigue.

Diagnosis

• Blood Tests and Urine Tests: For markers like serotonin or chromogranin A.
• Imaging: CT scan, MRI, or PET scan to identify tumors.
• Endoscopy: Visual inspection and biopsy of the ileum.
• Octreoscan: A specific scan for neuroendocrine tumors.

Treatment Options

• Surgery: Removal of the tumor and potentially affected areas of the small intestine.
• Medications: Somatostatin analogs (e.g., octreotide) to control symptoms.
• Radiation Therapy: Rarely used but may target metastases.
• Chemotherapy: To control tumor growth in advanced stages.
• Peptide Receptor Radionuclide Therapy (PRRT): For cases with widespread disease.

Prognosis and Follow-Up

• The prognosis varies depending on tumor size, spread, and response to treatment. Early detection and treatment generally improve outcomes.
• Regular follow-ups are crucial for monitoring recurrence or metastasis, typically involving blood tests and imaging.

Complications

• Bowel obstruction or perforation due to tumor growth.
• Carcinoid syndrome: Severe hormone-induced symptoms affecting quality of life.
• Liver metastases, impacting liver function.

Lifestyle & Prevention

• While specific preventive measures are not well established due to unknown causes, regular screenings for those with a family history or genetic predispositions may help.
• Healthy lifestyle choices, including a balanced diet and regular check-ups, are advised.

When to Seek Professional Help

• Persistent unexplained abdominal pain, diarrhea, or flushing.
• Symptoms of carcinoid syndrome like severe diarrhea and facial flushing warrant urgent medical evaluation.

Additional Resources

• American Society of Clinical Oncology (ASCO)
• Carcinoid Cancer Foundation
• Neuroendocrine Tumor Research Foundation (NETRF)

Tips for Medical Coders

• Ensure correct coding using ICD-10 code C7A.012.
• Be aware of associated conditions that might also require coding, like carcinoid syndrome (E34.0).
• Double-check for accurate input of metastatic sites or additional ICD codes for comprehensive documentation.